Debiopharm Group

About:

Debiopharm Group is a biopharmaceutical development specialist that in-licenses promising biologics and small molecule drug.

Website: http://www.debiopharm.com/

Twitter/X: DebiopharmHR

Top Investors: CARB-X

Description:

Debiopharm Group is a biopharmaceutical development specialist that in-licenses promising biologics and small molecule drug candidates. They develop their products for global registration and maximum commercial potential for out-licensing to pharmaceutical partners for sales and marketing.

Total Funding Amount:

$4.7M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Lausanne, Vaud, Switzerland

Founded Date:

1979-01-01

Founders:

Rolland-Yves Mauvernay

Number of Employees:

251-500

Last Funding Date:

2021-10-19

IPO Status:

Private

Industries:

© 2025 bioDAO.ai